Status:
NOT_YET_RECRUITING
Polish Version Dyspnea in Amyotrophic Lateral Sclerosis
Lead Sponsor:
Jakub Antczak
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Amyotrophic lateral sclerosis is a fatal disease with progressive degeneration of central and peripheral motor neurons. Weakness of pharyngeal and respiratory muscles lead to dyspnea, which is present...
Detailed Description
Amyotrophic lateral sclerosis (ALS) is a fatal disease with progressive degeneration of central and peripheral motor neurons with death occurring usually three to five years after onset. Weakness of p...
Eligibility Criteria
Inclusion
- Diagnosis of definite ALS, or probable ALS or probable, laboratory supported ALS according to revised Escorial criteria \[Brooks et al. 2000\].
- Complaining of dyspnea on exertion, or dyspnea at rest, or orthopnea without evidence of pulmonary or cardiac causes of dyspnea.
Exclusion
- Cognitive impairment severe enough to interfere with study process.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2028
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07178574
Start Date
October 1 2025
End Date
June 30 2028
Last Update
September 19 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.